Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.
Pathology Unit, Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, 56126, Pisa, Italy.
J Endocrinol Invest. 2023 Aug;46(8):1695-1703. doi: 10.1007/s40618-023-02044-0. Epub 2023 Feb 25.
Laboratory, imaging, and pathological features of Graves' disease (GD), although well characterized, have been barely correlated each other. Aim of the study was to link laboratory and ultrasound characteristics of GD with its pathological features.
We correlated laboratory and ultrasound data at the time of diagnosis in 28 consecutive GD patients who underwent thyroidectomy with their pathological features, i.e., lymphocytic infiltration and follicular hyperplasia (both classified as mild or severe).
Thyroid volume correlated positively with the levels of FT4 (P = 0.002, r = 0.42), FT3 (P = 0.011, r = 0.22), autoantibodies to thyroglobulin (TgAbs) (P = 0.016, r = 0.32), autoantibodies to thyroid peroxidase (TPOAbs) (P = 0.011, r = 0.34) and the extent of lymphocytic infiltration (P = 0.006 comparing mild to severe lymphocytic infiltration) but not with the levels of autoantibodies to the thyrotropin receptor (TRAbs) and to follicular hyperplasia. Compared to subjects with mild lymphocytic infiltration, those with severe lymphocytic infiltration showed higher levels of TgAbs (316 vs 0.0 IU/mL, P < 0.0001) and TPOAbs (295 IU/mL vs 14 IU/mL, P < 0.0001) and similar levels of TRAbs (7.5 vs 13 IU/mL, P = 0.68). Compared to patients with mild, those with severe follicular hyperplasia had similar levels of TgAbs (76 vs 30 IU/mL, P = 0.31) and TPOAbs (251 IU/mL vs 45 IU/mL, P = 0.26) but higher levels of TRAbs (39 vs 7.2 IU/mL, P < 0.001).
In GD, TgAbs and TPOAbs levels correlate with the extent of lymphocytic infiltration, TRAbs levels with the degree of follicular hyperplasia. Thyroid volume, the main factor influencing the severity of hyperthyroidism, is related to lymphocytic infiltration and not to follicular hyperplasia.
尽管 Graves 病(GD)的实验室、影像学和病理学特征已得到很好的描述,但它们之间几乎没有相关性。本研究旨在将 GD 的实验室和超声特征与其病理学特征联系起来。
我们将 28 例连续 GD 患者在诊断时的实验室和超声数据与他们的病理特征(淋巴细胞浸润和滤泡增生,均分为轻度或重度)进行了相关性分析。
甲状腺体积与 FT4(P=0.002,r=0.42)、FT3(P=0.011,r=0.22)、甲状腺球蛋白自身抗体(TgAbs)(P=0.016,r=0.32)、甲状腺过氧化物酶自身抗体(TPOAbs)(P=0.011,r=0.34)和淋巴细胞浸润程度(P=0.006,比较轻度和重度淋巴细胞浸润)呈正相关,但与促甲状腺激素受体自身抗体(TRAbs)和滤泡增生程度无关。与轻度淋巴细胞浸润相比,重度淋巴细胞浸润患者的 TgAbs(316 vs 0.0 IU/mL,P<0.0001)和 TPOAbs(295 IU/mL vs 14 IU/mL,P<0.0001)水平更高,而 TRAbs 水平相似(7.5 vs 13 IU/mL,P=0.68)。与轻度滤泡增生患者相比,重度滤泡增生患者的 TgAbs(76 vs 30 IU/mL,P=0.31)和 TPOAbs(251 IU/mL vs 45 IU/mL,P=0.26)水平相似,但 TRAbs 水平更高(39 vs 7.2 IU/mL,P<0.001)。
在 GD 中,TgAbs 和 TPOAbs 水平与淋巴细胞浸润程度相关,TRAbs 水平与滤泡增生程度相关。甲状腺体积是影响甲亢严重程度的主要因素,与淋巴细胞浸润有关,与滤泡增生无关。